Gene Therapy Market By Type (Germ Line Gene Therapy, Somatic Gene Therapy {Ex Vivo Gene Therapy, In Vivo Gene Therapy), By Therapy Area (Cancer, Infectious Diseases, Rheumatoid Arthritis, Genetic Disorders, Neurological Disorders, Others), By Vector Type (Viral Vectors {Adenoviruses, Retroviruses, Alphaviruses, Adeno-Associated Virus, Herpes Simplex Virus, Vaccinia Viruses, Others}, Non- Viral Vectors {Naked DNA, Oligonucleotides, Lipoplexes and Polyplexes}, Human Artificial Chromosome) By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027